Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction

Heart

Volumn 90, Issue 6, 2004, Pages 676-677

  Montalescot, G ^a,i   Andersen, H R ^b   Antoniucci, D ^c   Betriu, A ^d   De Boer, M J ^e   Grip, L ^f   Neumann, F J ^g   Rothman, M T ^h  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d HOSPITAL CLÍNIC   (Spain)

^e ISALA HOSPITAL   (Netherlands)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g Herzzentrum Bod Krozingen   (Germany)

^h LONDON CHEST HOSPITAL   (United Kingdom)

ⁱ Bureau 2 236   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CLINICAL TRIAL; HEART INFARCTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SHORT SURVEY; ST SEGMENT ELEVATION;

EID: 2442716273     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.016014     Document Type: Short Survey

References (10)

1. Smith SC Jr, Dove JT, Jacobs AK, et al. American College of Cardiology; American Heart Association task force on practice guidelines. Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines): executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2001;37:2215-39.
2. Brodie BR, Grines CL, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for AMI: final results from the primary angioplasty registry. Circulation 1994;90:156-62.
3. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
4. Dalby M, Bouzamondo A, Lechat PH, et al. Transfer for primary angioplasty versus thrombolysis in acute myocardial infarction. A meta-analysis. Circulation 2003;108:1809-14.
5. Aversano T, Aversano LT, Passamani E, et al for the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51.
6. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66.
7. Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and primary PTCA organization and randomized trial (RAPPORT) investigators. Circulation 1998;98:734-41.
8. Neumann FJ, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000;35:915-21.
9. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting far acute myocardial infarction. N Engl J Med 2001;344:1895-903.
10. Antoniucci D. The ACE trial - a prospective multicenter study of carbon coated stenting in AMI with and without abciximab. Transcatheter Cardiovascular Therapeutics 2002, 24-28 September 2002, Washington, DC, USA.